Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clancy Details Status Of New Comp. Effectiveness Institute, Impact On AHRQ

This article was originally published in The Gray Sheet

Executive Summary

The Agency for Healthcare Research and Quality may have to revise its role in the U.S. comparative effectiveness research arena to make room for a new independent nonprofit devoted to the field, but agency officials believe there is more than enough work to go around

You may also be interested in...



AHRQ Comparative Effectiveness Strategy Could Shift As Director Clancy Steps Down

Carolyn Clancy, who has served as director of the Agency for Healthcare Research and Quality for over 10 years, will stay in the post until a successor is named in the coming months.

Comparative Effectiveness Leaders Hash Out Methodology Questions

Top thinkers in the comparative effectiveness research community met recently in Washington, D.C., to hash over the best study methods for learning which interventions work best in which patients

Comparative Effectiveness Leaders Hash Out Methodology Questions

Top thinkers in the comparative effectiveness research community met recently in Washington, D.C., to hash over the best study methods for learning which interventions work best in which patients

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028753

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel